Mentioned On
Episode Mentions
Pharma and BioTech Daily · May 6, 2026
Sanofi Invests $294M in AI, FDA Approves Auvelity | Pharma and Biotech Daily
“$1.45 billion acquisition by ABV for CRAS inhibitor oncology therapeutics”
AI Center of Excellence and Digital Transformation in Drug DevelopmentFDA Approval Processes and Regulatory ModernizationCAR-T Cell Therapy Expansion Beyond Oncology
View AnalysisPharma and BioTech Daily · Apr 30, 2026
AstraZeneca's £300M UK Investment Resumes Amid FDA Pilot | Pharma and Biotech Daily
“Subject of Abhivi acquisition option; developing oral pancreas inhibitor for targeted cancer treatment”
FDA Real-Time Clinical Trial Review PilotAstraZeneca UK Investment and Drug PricingOncology Market Consolidation Strategy
View AnalysisPharma and BioTech Daily · Apr 29, 2026
AstraZeneca's Breztri Asthma Approval Boosts $80B Goal | Pharma and Biotech Daily
“Acquired by Abivy for $1.45 billion in BioBux deal focused on KRAS mutation targeting”
FDA Drug Approval and RescissionData Integrity in Drug DevelopmentAI-Designed Therapeutics
View Analysis